Literature DB >> 12034381

Effects of positive resection margin and tumor distance from anus on rectal cancer treatment outcomes.

P Terry Phang1, John K MacFarlane, Robert H Taylor, Rona E Cheifetz, Noelle Davis, John H Hay, Greg McGregor, Caroline Speers, Barry J Sullivan, Janet Pitts, Andrew J Coldman.   

Abstract

PURPOSE: Rectal cancer outcome depends on stage, technical aspects of surgical excision, and use of adjuvant chemoradiation. Here, we examine effects of positive resection margin and tumor distance from the anus in stage 2 and 3 cancers on 4-year disease-specific survival and recurrence.
METHODS: We reviewed all 495 rectal cancer patients registered in British Columbia in 1996.
RESULTS: There were 481 cases analyzed: 29 in situ, 134 stage 1, 107 stage 2, 100 stage 3, 83 stage 4, and 28 unknown stage. Survival was significantly affected by presence of positive resection margin in stage 2 and 3 cancers, P = 0.0001. Lower tumor distance from the anus for stage 2 and 3 cancers worsened survival, P = 0.0007, and overall recurrence, P =0.016, but not local recurrence, P = 0.11. Adjuvant postoperative combined radiation and chemotherapy in stage 2 and 3 cancers significantly improved survival, P = 0.070 and local recurrence, P = 0.018, but not overall recurrence, P = 0.19.
CONCLUSIONS: Presence of positive resection margin and tumor distance from the anus affect survival, local recurrence, and overall recurrence. Adjuvant postoperative combined radiation and chemotherapy improved our outcomes. Our local recurrence rates for rectal cancers are worse than currently reported standards of less than 10%. Improved surgical excision and use of adjuvant preoperative radiation and chemotherapy may improve outcome.

Entities:  

Mesh:

Year:  2002        PMID: 12034381     DOI: 10.1016/s0002-9610(02)00840-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  10 in total

Review 1.  Total mesorectal excision: technical aspects.

Authors:  P Terry Phang
Journal:  Can J Surg       Date:  2004-04       Impact factor: 2.089

Review 2.  Evolving rectal cancer management in British Columbia.

Authors:  P Terry Phang
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

3.  Effects of change in rectal cancer management on outcomes in British Columbia.

Authors:  P Terry Phang; Colleen E McGahan; Greg McGregor; John K MacFarlane; Carl J Brown; Manoj J Raval; Rona Cheifetz; John H Hay
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

4.  Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: the Freiburg experience (1989-2002).

Authors:  Christian Weissenberger; Michael Geissler; Florian Otto; Annette Barke; Karl Henne; Georg von Plehn; Alex Rein; Christine Muller; Susanne Bartelt; Michael Henke
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

5.  Anterior resection for rectal carcinoma - risk factors for anastomotic leaks and strictures.

Authors:  Ashok Kumar; Ram Daga; Paari Vijayaragavan; Anand Prakash; Rajneesh Kumar Singh; Anu Behari; Vinay K Kapoor; Rajan Saxena
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

6.  Transanal excision with adjuvant therapy for pT1N0 rectal tumors with high-risk features offers equivalent survival to radical resection: A National Cancer Database analysis.

Authors:  Katherine A Hrebinko; Katherine M Reitz; Maryam K Mohammed; Ibrahim Nassour; Andrew R Watson; Kellie E Cunningham; David S Medich; James P Celebrezze; Jennifer M Holder-Murray
Journal:  J Surg Oncol       Date:  2021-10-27       Impact factor: 3.454

7.  Occurrence and prognostic value of circumferential resection margin involvement for patients with rectal cancer.

Authors:  Cun Wang; Zong-guang Zhou; Yong-yang Yu; Ye Shu; Yuan Li; Lie Yang; Li Li
Journal:  Int J Colorectal Dis       Date:  2009-01-20       Impact factor: 2.571

8.  Biweekly oxaliplatin, raltitrexed, 5-fluorouracil and folinic acid combination chemotherapy during preoperative radiation therapy for locally advanced rectal cancer: a phase I-II study.

Authors:  A Avallone; P Delrio; C Guida; F Tatangelo; A Petrillo; P Marone; L G Cascini; B Morrica; S Lastoria; V Parisi; A Budillon; P Comella
Journal:  Br J Cancer       Date:  2006-05-30       Impact factor: 7.640

9.  Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.

Authors:  Yasmin Abu-Ghanem; Jacob Ramon; Raanan Berger; Issac Kaver; Edi Fridman; Raya Leibowitz-Amit; Zohar A Dotan
Journal:  World J Surg Oncol       Date:  2017-11-02       Impact factor: 2.754

10.  Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer.

Authors:  P T Phang; H Kennecke; C E McGahan; J Macfarlane; G McGregor; J H Hay
Journal:  Curr Oncol       Date:  2008-04       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.